First-line therapy with temozolomide induces regression of primary CNS lymphoma
- 28 May 2002
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (10) , 1573-1574
- https://doi.org/10.1212/wnl.58.10.1573
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphomaAnnals of Neurology, 2002
- Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent PatientsOncology, 2001
- Primary central nervous system lymphoma 1991-1997Cancer, 2001
- PCV salvage chemotherapy for recurrent primary CNS lymphomaNeurology, 2000
- Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.JNCI Journal of the National Cancer Institute, 2000
- Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of PatientsJournal of Neuro-Oncology, 1999
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998